Stuart M. Essig, PhD

Executive Chair, Integra LifeSciences Holdings Corporation

Independent Director

Age: 62

Director since:
July 2017

Finance (Chair)
Governance and Corporate Responsibility

Other current public company director service:

  • Integra LifeSciences Holdings Corporation (since 1997) (Executive Chair since Feb. 2024) (Chair, 2012 - 2024)
  • Orthofix Medical Inc. (since Jan. 2023)

Former public company director service:

  • Owens & Minor, Inc. (Oct. 2013 - Aug. 2019)
  • SeaSpine Holdings Corporation (Jun. 2015 - Jan. 2023) (Lead Director, Jul. 2015 - Jan. 2023)
  • St. Jude Medical, Inc. (Mar. 1999 - Jan. 2017)
  • Vital Signs, Inc. (1998 - 2002)
  • Zimmer Biomet Holdings, Inc. (2005 - 2008)


Integra LifeSciences Holdings Corporation

  • Executive Chair of Board of Directors (since February 2024)
  • Non-Executive Chair of Board of Directors (June 2012 – February 2024)
  • Executive Chair of Board of Directors (January 2012 – June 2012)
  • Member of Board of Directors (since 1997)
  • Chief Executive Officer (1997 – 2012)

Prettybrook Partners LLC

  • Managing Director (since 2012)

Wellington Partners Advisory AG

  • Venture Partner (since 2013)

TowerBrook Capital Partners

  • Senior Advisor (since 2010)

Goldman, Sachs and Co.

  • Managing Director, M&A, specializing in the medical device, pharmaceutical and biotechnology sectors (1987 – 1997)


  • Executive Leadership: Extensive executive management experience and deep strategic expertise in the global healthcare industry gained from over 25 years of experience in developing, executing and overseeing the corporate strategy of Integra LifeSciences Holdings Corporation, a manufacturer of medical devices used in neurosurgery and orthopedic surgery, as its Chief Executive Officer for 15 years, board chair from 2012 to 2024 and executive chair since 2024, during which time revenues increased over 100-fold.
  • Financial Acumen: Substantial knowledge and experience in the review and preparation of financial statements and a strong understanding of complex financial and accounting topics, internal controls over financial reporting, and financial planning developed over the course of his career in various financial management and banking roles, including through his investment banking, chief executive officer and significant outside board experiences.
  • Corporate Finance: Deep knowledge of capital markets, investment banking, and mergers and acquisitions acquired throughout the course of his career in investment banking, during which he specialized in the medical device, pharmaceutical and biotechnology sectors, and applied throughout his career at Integra LifeSciences Corporation and his outside board service.
  • Mr. Essig also brings significant corporate strategy, corporate governance, science, technology and R&D, human capital management, international business, operations and risk oversight skills and experience to the Board.


  • BA, School of Public and International Affairs at Princeton University
  • MBA, University of Chicago
  • PhD, Financial Economics, University of Chicago